Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 8,127

Document Document Title
WO/2013/065383A1
A compound represented by structural formula (A) or a salt thereof. The compound or the salt thereof is produced suitably from a microorganism belonging to the genus Saccharothrix and can be used suitably as a prostaglandin production in...  
WO/2013/067432A1
The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. ...  
WO/2013/064687A2
The present invention belongs to the field of pharmaceutical industry and specifies the process for preparing clavulanic acid by using a microorganism, comprising the steps of providing a microorganism being capable of producing clavulan...  
WO/2013/064687A3
The present invention belongs to the field of pharmaceutical industry and specifies the process for preparing clavulanic acid by using a microorganism, comprising the steps of providing a microorganism being capable of producing clavulan...  
WO/2013/061919A1
The purpose of the present invention is to provide: a novel compound useful as an anti-mold substance; and a method for producing the compound. The present invention relates to: a compound represented by formula (I0) (wherein R1 represen...  
WO/2013/059507A1
The invention provides isolated nucleic acid encoding one or more gene products that allow for degradation of caffeine and related structures, and for preparation of intermediates in that catabolic pathway. Further provided are methods o...  
WO/2013/058582A2
The present invention relates to a preparation method for an ansamycin glycoside or a non-benzoquinone geldanamycin glycoside having an ansamycin backbone using a glycosyltransferase, a non-benzoquinone geldanamycin glycoside, and a phar...  
WO/2013/058582A3
The present invention relates to a preparation method for an ansamycin glycoside or a non-benzoquinone geldanamycin glycoside having an ansamycin backbone using a glycosyltransferase, a non-benzoquinone geldanamycin glycoside, and a phar...  
WO/2013/041935A1
The present invention provides a process for the preparation of lycopene containing oleoresin and lycopene crystals for human consumption. The present invention provides an efficient process for the preparation of lycopene crystals from ...  
WO/2013/036787A2
Provided herein are cell-free systems for generating carbapenems, e.g., a compound of the Formula (I): or salts thereof; wherein (II), R1, R2, R3, R4, R5, and R6 are defined herein. Also provided are pharmaceutical compositions comprisin...  
WO/2013/036787A3
Provided herein are cell-free systems for generating carbapenems, e.g., a compound of the Formula (I): or salts thereof; wherein (II), R1, R2, R3, R4, R5, and R6 are defined herein. Also provided are pharmaceutical compositions comprisin...  
WO/2013/023391A1
Disclosed are a Pseudonocardia sp. and a method for preparing deoxynyboquinone by the same. Pseudonocardia sp. SCSIO 01299 was deposited on July 18, 2011, at the China Center for Type Culture Collection (CCTCC), address: Wuhan University...  
WO/2013/017517A1
A process for the manufacture of (R)-(-)-1 -(2,4-dichloro-phenyl)-2-imidazole-1 -yl- ethanol (I) by biocatalytic asymmetric reduction of 1 -(2,4-dichloro-phenyl)-2-imidazole- 1 -yl-ethanone (II) is provided. The invention also provides a...  
WO/2013/006953A1
Polypeptides having alkanoyl-CoA activity have been identified and characterized, as have nucleic acids encoding these polypeptides. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds in organisms. ...  
WO/2013/006953A9
Polypeptides having alkanoyl-CoA activity have been identified and characterized, as have nucleic acids encoding these polypeptides. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds in organisms. ...  
WO/2013/006953A8
Polypeptides having alkanoyl-CoA activity have been identified and characterized, as have nucleic acids encoding these polypeptides. Expression or over-expression of the nucleic acids alters levels of cannabinoid compounds in organisms. ...  
WO/2013/003744A2
Embodiments of the present invention relate to methods for the biosynthesis of di- or trifunctional C7 alkanes in the presence of isolated enzymes or in the presence of a recombinant host cell expressing those enzymes. The di- or trifunc...  
WO/2013/002561A2
The present invention relates to a Kitasatospora sp. DG09 strain, to a tyrosinase produced from same, and to a method for producing 5,6-dihydroxyindole using same. More particularly, the present invention relates to the Kitasatospora sp....  
WO/2013/002561A3
The present invention relates to a Kitasatospora sp. DG09 strain, to a tyrosinase produced from same, and to a method for producing 5,6-dihydroxyindole using same. More particularly, the present invention relates to the Kitasatospora sp....  
WO/2013/003744A3
Embodiments of the present invention relate to methods for the biosynthesis of di- or trifunctional C7 alkanes in the presence of isolated enzymes or in the presence of a recombinant host cell expressing those enzymes. The di- or trifunc...  
WO/2012/175570A1
The invention relates to a method for metabolic evolution of a variant of a natural small aromatic molecule product of a metabolic pathway, by somatic in vivo assembly and recombination of said metabolic pathway employing a gene mosaic o...  
WO/2012/171666A1
A method comprising the steps (a) contacting a hydrocarbon comprising a hydroxyl group with a biological agent having oxygen-dependent and cofactor-dependent carbohydrate oxidase activity in the presence of oxygen and carbohydrate oxidas...  
WO/2012/171966A1
The present invention relates to a method for the preparation of disaccharides and polysaccharides by means of the regioselective hydrolysis of monosaccharide units in the primary position.  
WO/2012/171070A1
The present invention relates to a method of producing carbamoyl phosphate, the method comprising reacting ammonia, ATP, bicarbonate and CO2, or a hydrated form thereof, in a composition in the presence of a carbamate kinase, wherein the...  
WO/2012/170793A1
Processes and methods for making biobased tetrahydrofuran products from renewable carbon resources are described herein.  
WO/2012/167350A1
There is herein described a nanovesicle comprising a bilayer of porphyrin-phospholipid conjugates. Each porphyrin-phospholipid conjugate comprises one porphyrin, porphyrin derivative or porphyrin analog covalently attached to a lipid sid...  
WO/2012/170793A8
Processes and methods for making biobased tetrahydrofuran products from renewable carbon resources are described herein.  
WO/2012/170520A1
The present disclosure provides methods to produce substituted furans (e.g., halomethylfurfural, hydroxymethylfurfural, and furfural), by acid-catalyzed conversion of biomass using a gaseous acid in a multiphase reactor, such as a fluidi...  
WO/2012/166842A1
Methods and systems for increasing the yield and/or throughput of a product produced in a multi-step equilibrium pathway are described. Product yield and/or throughput is increased through supersaturation of a solubility-limited substrat...  
WO/2012/166406A1
Methods and systems for increasing the yield and/or throughput of a product produced in a multi-step equilibrium pathway are described. Product yield and/or throughput is increased through supersaturation of a solubility-limited substrat...  
WO/2012/156151A1
A method for converting an ω-aminocarboxylic acid or ester thereof into the corresponding lactam, comprising the steps (a) providing the ω-aminocarboxylic acid or ester thereof and (b) contacting the ω-aminocarboxylic acid or ester th...  
WO/2012/147674A1
The present invention provides: a process for producing 2R,4R-monatin with good yield not using an expensive starting material D-Trp but using an inexpensive starting material L-Trp; and others. Specifically, the present invention provid...  
WO/2012/147905A1
Provided is a promoter activity enhancer. A promoter activity enhancer comprising a compound represented by formula (I).  
WO/2012/147750A1
The purpose of the present invention is to provide a compound that can regulate growth of plants. A compound selected from the group consisting of (A) and (B) has plant growth-regulating activity. (A) 3H-imidazo[4,5-d] [1,2,3]triazin-4,6...  
WO/2012/145848A1
This invention relates to a process for the production of microalgal biomass for species of the genus Haematococcus. Using this process the rate of biomass production and the biomass astaxanthin content are increased. An embodiment of th...  
WO/2012/140894A1
A compound produced in tea leaves by fermentation and not found in raw material tea leaves is obtained by fermenting for 3 to 10 days using black rice malt and particularly using second-picking tea as the tea leaves, and used as an activ...  
WO/2012/141661A2
A plastic container (10) and removable interlocking lid (12) forming in combination a container assembly is disclosed. In cross-sectional view, external wall (20) of the container at its rim section has a tongue (22) extending upwards an...  
WO/2012/125091A1
Callus and suspension cultures of cells, tissues and organs of the genus Nigella (Ranunculaceae) producing melanin, as an induced component and a process for extraction of melanin therefrom are provided. The callus and suspension culture...  
WO/2012/118225A1
The present invention provides a method for producing PQQ using a bacterium belonging to the genera Methylobacterium or Hyphomicrobium, which has been modified to enhance the expression of pqq gene cluster and/or gene(s) encoding a precu...  
WO/2012/104176A1
A method for fermenting a microorganism, producing a compound of interest, in a culture medium comprising: adding a browned glucose solution to the culture medium, wherein the browned glucose solution is a glucose solution that has been ...  
WO/2012/101564A2
This invention relates to novel compounds obtained by fermentation of Myxobacteria strain (PM0670013/ MTCC 5570). The present invention further relates to the processes for the production of the novel anti-inflammatory compounds, to the ...  
WO/2012/096553A2
The present invention relates to a method for the preparation of nicotinic acid, which comprises the step of obtaining a culture solution containing quinolinic acid by incubating a microorganism having an ability to produce quinolinic ac...  
WO/2012/095244A3
The present invention discloses a process for preparing an active pharmaceutical ingredient (API) or intermediates thereof, notably particular step in the synthesis of an intermediate useful for example in the preparation of statins, by ...  
WO/2012/096553A3
The present invention relates to a method for the preparation of nicotinic acid, which comprises the step of obtaining a culture solution containing quinolinic acid by incubating a microorganism having an ability to produce quinolinic ac...  
WO/2012/095244A2
The present invention discloses a process for preparing an active pharmaceutical ingredient (API) or intermediates thereof, notably particular step in the synthesis of an intermediate useful for example in the preparation of statins, by ...  
WO/2012/089349A3
The present invention relates to novel polyketide compounds and to enzymes and production organisms for obtaining such novel polyketide compounds. Polyketides of the present invention include non-natural, chemically active extender units...  
WO/2012/089843A2
The technology disclosed herein relates to novel methods and compositions for the production processes of algae cell components from algae of the genus Scenedesmus. The extractability of algae cellular components is improved and the proc...  
WO/2012/089349A2
The present invention relates to novel polyketide compounds and to enzymes and production organisms for obtaining such novel polyketide compounds. Polyketides of the present invention include non-natural, chemically active extender units...  
WO/2012/062951A1
The invention relates to bacterial strains of Duganella spp., obtained from the rhizosphere of wild and cultivated olive trees. Preferably, the strains are CECT 7779, CECT 7780 and CECT 7781, and more preferable still, the bacterial stra...  
WO/2012/064195A3
The present invention relates to the field of biotransformation of furanic compounds. More particular the present invention relates to novel genetically modified cells with improved characteristics for biocatalytic transformation of fura...  

Matches 151 - 200 out of 8,127